Rivka Sachdev is a Neurology physician affiliated with Mount Sinai Beth Israel. OpenAlex indexes 12 publications with 614 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
156 William St Fl 11
New York, NY 100385323
Telephone
646-962-5168Registry record last updated 1 Aug 2019.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
82.9%Neuromuscular Blocker82.9%Onabotulinumtoxina100%Part B, office-administered≥12 patientsNervous system
15.7%Aromatic Amino Acid Decarboxylation Inhibitor8.4%Carbidopa-Levodopa77%Carbidopa-Levodopa Er21%Carbidopa3%Part D<11 patientsCholinesterase Inhibitor1.3%Rivastigmine81%Donepezil Hcl19%Part D<11 patients+ 10 more classes in this area
Cardiovascular
1.4%Beta blocker1.4%Propranolol Hcl Er54%Propranolol Hcl46%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <i>LRRK2</i> G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environment
bioRxiv (Cold Spring Harbor Laboratory)
2024 - Neuropsychiatric characteristics of GBA-associated Parkinson disease
Journal of the Neurological Sciences
2016 - The Broadening Clinical Spectrum Associated with ATP1A3 Mutations (P5.397)2016
Similar KOLs
Other experts from the same institution or the same specialty.
Ramesh Gowda, MD
Mount Sinai Beth Israel
Michael Serby, MD
Mount Sinai Beth Israel
Albert Min, MD
Mount Sinai Beth Israel
Maryna Skliut, MD
Mount Sinai Beth Israel
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”